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Abstract
BACKGROUND: Diabetes mellitus (DM) is a major health-care burden worldwide. 
AIM: The aim of the study was to explore how the quality of life (QoL) of DM patients could be affected in the Aseer 
Province of the Kingdom of Saudi Arabia (KSA).
METHODS: A cross-sectional, multicenter study in DM patients of both sexes and all age groups in Aseer Province 
were done using a validated self-administered questionnaire. The study was conducted between April 1, 2018 and 
November 25, 2018.
RESULTS: A total of 418 patients completed our questionnaire, of which 240 (58%) were male and 178 (42%) 
were female. Furthermore, 50.23% were married and 104 (24.16%) were illiterate. We found that 403 (96.42%) 
respondents had type-2 DM and 315 (75.35%) had a family history of DM. In addition, 132 (31.57%) respondents were 
on monotherapy whereas only 61 (14.59%) were using combination therapy. Hypertension was the most prevalent 
comorbidity (166, 39.71%) and peripheral neuropathy the most prevalent complication of DM (157, 37.56%).
CONCLUSION: DM had a significant impact on QoL among patients from Aseer Province in KSA. Our study 
underscores the importance of generating data on QoL among DM patients.
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Introduction
Diabetes mellitus (DM) is a chronic disease 
that can affect quality of life (QoL) if the desired 
treatment outcomes are not achieved [1], [2]. Therefore, 
patients with DM should be counseled and educated 
about the impact of DM on their QoL, and encouraged 
to adhere to pharmacologic and non-pharmacologic 
management [3].
The prevalence of DM worldwide has been 
increasing worldwide and has been projected be ~370 
million by 2030 [4]. There are two common types of 
DM, type 1 and type 2, and the latter represents ~90% 
of DM worldwide [5]. Over the past four decades, the 
Kingdom of Saudi Arabia (KSA) has witnessed major 
socioeconomic changes. As a result, the overall 
prevalence of DM among adults in KSA is ~25% [6].
QoL represents the ultimate goal of all 
health interventions [7]. It provides deep insight 
and information, irrespective of clinical data, on 
how the patient feels [8]. Evidence suggests that in 
DM, psychosocial factors play an important part in 
self-care, acceptance of therapeutic regimens, and 
treatment success and that metabolic measures (e.g., 
glycemic control) are poorly correlated with QoL [9]. 
DM complications have been found to have a negative 
effect on QoL [10]. Therefore, the main objective of 
DM treatment is to prevent DM complications and, 
therefore, improve the QoL of patients [1], [2]. An 
improvement in QoL not only benefits the patients but 
also reduces the social, financial, and psychological 
burden related to DM [1], [2].
The paucity of data related to QoL in the Aseer 
Province of KSA prompted us to evaluate the QoL of 
patients with DM and related complications.
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Methods
Ethical approval of the study protocol
The study protocol was approved from the 
Regional Ethical Committee of the Aseer Province 
(REC-2018-03-055). The purpose of the study was 
explained to respondents, and questions were 
administered only after seeking their consent for 
participation. The personal information of patients was 
not collected.
Study design
A cross-sectional study was conducted 
between April 1, 2018 and November 25, 2018. The 
study cohort was patients with type-1 and -2 DM in five 
primary care centers in the cities of Abha and Khamis 
Mushait in the Aseer Province in Southwest KSA.
Sample size and sampling method
The sample size (n) was calculated based on 
the Cochran equation. The calculated sample size was 
385. A convenient sampling method was used in this 
study. Patients with DM were invited to participate in 
this study.
Study instrument and data collection
A self-administered questionnaire was 
adapted from the literature [11]. This validated self-
administered questionnaire comprised 35 questions 
with four domains: Demographic and socioeconomic 
factors; clinical characteristics; QoL; and compliance 
of QoL.
Then, the study was carried out in a systematic 
and sequential manner. Step 1 involved development 
and validation of the questionnaire: A focus group 
of academicians and DM consultants determined 
the domains affecting QoL. Step 2 comprised a pilot 
study conducted for validation. The World Health 
Organization Brief Quality of Life Questionnaire was 
used for comparison [11]. Step 3 was questionnaire 
administration; the questionnaire was administered in 
person during daily visits to health facilities in which the 
study was carried out.
Statistical analysis
Data were analyzed descriptively using SPSS 
v21 (IBM, Armonk, NY, USA). The Kruskal–Wallis test 
of significance (p < 0.05) was undertaken to assess the 
association between adherence and DM-specific QoL. 
A multiple regression analysis (backward-selection 
method) was used to identify the independent predictors 
of DM-specific QoL.
Results
Patient demographics
Out of 439 study participants, 417 (95.2%) 
completed the questionnaire. Of these 417 participants, 
240 (58%) were male and 178 (42%) were female. Most 
respondents were elderly (159, 38.08%). The lowest 
number of respondents (21, 5.02%) was <20 years 
of age. Furthermore, 210 (50.23%) respondents were 
married. In addition, 55 (13.15%) and 104 (24.16%) 
respondents were illiterate, whereas 94 (44.48%) had 
attained education at university level. Furthermore, 150 
(35.88%) were unemployed whereas 49 (11.75%) were 
self-employed (Table 1).
Patient distribution by clinical 
characteristics and treatment type
Of the 418 people who completed the 
questionnaire, 403 (96.42%) had type-2 DM and 315 
(75.35%) had a family history of DM. Furthermore, 
148 (35.40%) had an underlying chronic history of DM 
from 5 years, whereas 27 (6.45%) were diagnosed 
recently (<1 year) with DM. In addition, 132 (31.57%) 
respondents were on monotherapy whereas 61 
(14.59%) respondents were using combination therapy 
involving insulin. All patients had comorbidity, with 
hypertension being the most prevalent (166, 39.71%), 
followed by asthma (59, 14.11%) and dyslipidemia (58, 
13.88%). Peripheral neuropathy was the most common 
DM-induced complication (157, 37.56%), followed by 
diabetic retinopathy (93, 22.25%) (Table 2).
Self-awareness of patients
We found that 226 (54.07%) respondents were 
well aware of hypoglycemic symptoms. Furthermore, 
181 (43.30%) respondents were physically inactive and 
Table 1: Demographics of questionnaire respondents
Characteristic Number Percentage
Sex
Male 243 58
Female 174 42
Age (years)
<20 21 5
20–39 56 13
40–59 136 33
60–79 157 38
>80 47 11
Marital status
Unmarried 207 50
Married once 56 13
Married multiple times 70 17
Separated or divorced 53 13
Widowed 31 7
Education
None 104 25
Primary level 101 24
Secondary level 118 28
University 94 23
Work status
Government employee 78 19
Private employee 42 10
Self-employed 69 17
Unemployed 49 12
Pensioner 179 43
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108 (25.84%) were carrying out physical activity for 
<30 min. In addition, 338 (88.85%) of respondents did 
not know about their level of glycated hemoglobin, and 
368 (88.40%) were unaware of their body mass index. 
Worryingly, 163 (39.0%) of respondents did not follow 
their dietician’s advice and 332 (79.42) did not use or 
kept a necklace/bracelet saying that they had DM with 
them.
Table 2: Patient distribution by clinical characteristics and 
treatment type
Characteristic Number Percentage
Type of DM
1 399 96
2 18 4
Family history of DM
Yes 317 76
No 100 24
How long you have been diagnosed with DM?
<1 year 27 6
1–5 years 147 35
5–10 years 118 28
>10 years 125 30
Type of your therapeutic regimen
Monotherapy 132 32
Combination therapy including metformin 184 44
Combination therapy without metformin 40 10
Combination therapy including insulin 61 15
Comorbidity
None 93 22
One comorbidity 187 45
Two comorbidities 93 22
More than two comorbidities 44 11
DM complication
None 64 15
One complication 80 19
Two complications 188 45
More than two complications 85 20
DM: Diabetes mellitus.
We found that 372 (89%) respondents were 
satisfied with their medications and that 90 (22%) had an 
unpleasant experience with their existing drug therapy. 
Furthermore, 193 (46.45%) respondents felt worrisome 
about the possible side effects of their drug therapy and 
95 (22.8%) used to skip their medications at times, with 
194 (46.6%) of them experiencing some side effects 
from their drugs. In addition, 52.6% of patients “felt 
isolated” for being served a different diet and 64.3% 
“hated being watched for that they ate.” Furthermore, 
77.9% “felt bad for not being able to eat what they like.” 
More than 50% of respondents felt depressed because 
of the underlying disease and 91.1% worried about 
their children getting affected with the same disease 
(Tables 3 and 4).
Patient-related QoL
More than 70.0% of respondents stated 
that DM affected their general health and routine 
activities, such as working, shopping, and travelling. 
However, 23.4% of respondents stated that DM did 
not affect their capacity to work. Furthermore, 12% 
of respondents were undecided if DM affected their 
work capacity, whereas 66.26% felt strongly that 
absence from work was because of DM. More than 
50% of respondents attributed their disassociation from 
family/social occasions to DM. In addition, 60.0% of 
Table 4: Linear regression multivariable analysis of the 
relationship between clinical characteristics and overall QoL 
score
Variable Standardized 
coefficient (beta)
95% CI p-value
Type of DM
1 Reference Reference Reference
2 0.094 −0.145–12.142 0.056
Family history of DM
Yes Reference Reference Reference
No 0.234 4.146–9.704 0.000
How long you have been diagnosed with DM?
<1 year 0.040 −3.134–7.253 0.436
1–5 years 0.233 3.197–9.152 0.000
5–10 years 0.083 −0.824–−5.458 0.148
>10 years Reference Reference Reference
Therapeutic regimen
Monotherapy Reference Reference Reference
Combination therapy including 
metformin
−0.31 −8.606–−3.154 0.000
Combination therapy without 
metformin
0.028 −3.127–5.50 0.584
Combination therapy including 
insulin
−0.102 −0.060–7.341 0.054
Comorbidity
None 0.231 2.56–11.46 0.002
One comorbidity 0.25 −3.44–4.70 0.762
Two comorbidities −0.27 −5.25–3.63 0.720
Three or more than three 
comorbidities
Reference Reference Reference
DM complications
None 0.455 12.207–19.702 0.000
One complication 0.089 −0.648–6.469 0.109
Two compilations 0.117 −0.036–5.925 0.047
Three complications Reference Reference Reference
QoL: Quality of life, CI: Confidence interval.
respondents stated that their disease had an impact 
on routine activities such as long talks, conversations, 
prayers, sleeping, and travelling on long road 
trips, and 29.2% stated that DM did not affect their 
relationship with friends/wife/children/coworkers. 
However, 50% of respondents were undecided on 
whether DM affected their sexual health, and 50% of 
respondents felt that DM affected their sexual health 
(Table 5).
Table 5: Mean QoL scores in various domains
Domain Mean ± SD
Patient’s self-awareness of DM 38.63 ± 18.43
Patient’s experience of drugs and DM 35.25 ± 14.447
Patient-related QoL 49.57 ± 25.69
Overall QoL 41.17 ± 12.662
QoL: Quality of life, DM: Diabetes mellitus.
Table 3: Linear regression multivariable analysis for the 
relationship between demographic characteristics and overall 
QoL score
Variable Standardized 
coefficient (beta)
95% CI p-value
Sex
Male Reference Reference Reference 
Female −0.251 −8.824–−4.033 0.000
Age (years)
<20 Reference Reference Reference
20–39 −0.048 −7.756–4.232 0.564
40–59 −0.290 −13.311–−2.326 0.000
60–79 −0.509 −18.719–−7.833 0.005
>80 −0.307 −18.418–−6.121 0.000
Marital status
Unmarried Reference Reference Reference
Married once 0.145 1.704–9.031 0.004
Married multiple times −0.010 −3.726–3.035 0.841
Separated/divorced −0.153 −9.540–−2.051 0.002
Widowed −0.050 −7.103–−2.267 0.311
Education
None Reference Reference Reference
Primary level 0.098 −0.349 to 6.143 0.080
Secondary Level 0.264 4.278 to 10.529 0.000
University 0.416 9.292 to 15.90 0.000
Work status
Government employee 0.252 3.91–12.44 0.000
Private employee 0.055 −2.63–7.284 0.358
Self-employed −0.106 −7.99–0.754 0.105
Unemployed Reference Reference Reference
Pensioner −0.103 −6.40–1.120 0.168
QoL: Quality of life, CI: Confidence interval.
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Discussion
QoL evaluation is a fundamental component 
when providing healthcare in patients with DM. In recent 
years, there has been growing appreciation of the 
patient’s perspective on health, disease, and medical 
treatments. DM prevalence in KSA is underestimated. 
Only a few national/regional DM registries are available 
to support DM research and provide reliable data on 
various aspects of the disease [11]. We investigated 
QoL among patients with DM, with a focus on the 
clinical, mental and psychosocial factors that affect 
QoL.
Most respondents were elderly, married, and 
illiterate. A sex-specific significant difference in QoL was 
not found among study participants. These results are 
in accordance with data from Brown et al., who reported 
that neither sex, education level nor age affected QoL 
significantly [12]. However, in western countries, lower 
QoL in women suffering from DM was reported by 
Rubin and Peyrot in 2004 [3]. Similar results have been 
reported by Redekop et al. and Aghamollaei et al. in 
2002 and 2003, respectively [13], [14], [15].
We found that 96.42% of respondents had 
type-2 DM, with 75.35% having a family history of DM. 
Most respondents had an underlying chronic history 
of DM. Family history was found to be a stressful 
factor and reduced their QoL because they felt that 
their children were equally susceptible to the disease. 
Hypertension and asthma were common comorbidities, 
whereas peripheral neuropathy and retinopathy were 
common complications of DM. Moreover, respondents 
with neuropathic pain experienced a reduction in sleep, 
walking, and ability to undertake domestic duties. DM 
impairs all dimensions of health [11], [15]. Brown et al. 
reported that the type and duration of DM had an impact 
on QoL. DM complications, such as retinopathy and 
peripheral sensory neuropathy, have been associated 
with poor QoL in several studies, and painful diabetic 
neuropathy has a significant impact on QoL [16], [17].
Satisfaction with use of medications has a 
key role in terms of treatment compliance. Several 
studies have reported that long-term maintenance of 
drug therapy and glycemic control is dependent on 
adherence to medication and lifestyle changes. Most 
respondents (89%) were satisfied with the medications 
they were taking [18]. However, factors such as 
unpleasant taste and the side effects of medications 
had an impact on medication adherence among study 
respondents. More than 50% of respondents felt 
depressed because of their underlying disease and 
were worried about their children getting affected 
by DM. The results of our study are in accordance 
with those of Farias et al. [19]. They suggested that 
the QoL of patients with DM may influence treatment 
adherence, improve clinical outcomes satisfactorily, 
and reduce the prevalence of morbidity and mortality 
and disease progression. The relationship between 
QoL and treatment adherence remains controversial. 
Some scholars have shown the highest QoL level 
in patients with DM to be associated with better 
treatment adherence, whereas other researchers 
have not identified this association [19], [20].
Self-awareness and management of the 
complications and symptoms of DM have been 
positively correlated with QoL [21]. Self-management 
activities demand require effort, which many people 
find difficult to incorporate into their daily life [22], [23]. 
More than 50% of respondents were found to be 
self-aware about symptom management but these 
respondents were also found to be physically inactive. 
These results are in accordance with other studies that 
have reported that the duration of DM is associated 
with the level of DM knowledge [24]. Yun et al. and 
Kamel et al. observed a linear relationship between 
overall knowledge of DM and DM management. 
However, in another study, it was reported that people 
with DM lacked knowledge and, consequently, had low 
levels of self-care practices [25], [26]. Another study 
reported that exercise was associated with improved 
QoL among people with DM [27].
DM affects the QoL of the patient and his/
her family due to its chronic nature, and its severity 
has been found to be associated with lower QoL [21]. 
Social isolation and dietary restriction had a negative 
impact on QoL among study respondents: >50% of 
respondents felt isolated for being served a different 
diet to that of other people. Moreover, monitoring what 
DM patients eat was found to have a negative impact 
on their QoL in the present study. Seventy-percent of 
respondents faced difficulties in routine activities, such 
as working, shopping, travelling, and praying.
Conclusion
DM had a significant impact on QoL among 
patients from the Aseer Province of KSA. Moreover, DM 
patients should be involved in awareness and counseling 
sessions to gain more knowledge regarding DM and its 
consequences. Our study underscores the importance 
of generating more data on QoL among DM patients.
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